Autologous fibrin scaffolds cultured dermal fibroblasts and enriched with encapsulated bFGF for tissue engineering

Journal of Biomedical Materials Research - Part A

Volumn 99 A, Issue 4, 2011, Pages 648-654

  De La Puente, Pilar ^a   Ludeña, Dolores ^b   Fernández, Ana ^a   Aranda, Jose L ^b   Varela, Gonzalo ^b   Iglesias, Javier ^a  

^a Tissue Establishment San Francisco Clinic Foundation   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

dermal fibroblast; encapsulation; fibrin; fibroblast growth factor; scaffold

Indexed keywords

ALGINATE MICROCAPSULES; ANIMAL MODEL; BASIC FIBROBLAST GROWTH FACTOR; BIOCOMPATIBLE SCAFFOLDS; CELL COUNT; CELLULAR ATTACHMENTS; COLLAGEN SYNTHESIS; CONTROLLED RELEASE; DERMAL FIBROBLASTS; FIBRIN; FIBRIN SCAFFOLD; FIBRINOGEN CONCENTRATION; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; IN-VITRO; IN-VIVO; MULTIPLE APPLICATIONS;

CELL CULTURE; CELL PROLIFERATION; ENCAPSULATION; FIBROBLASTS; NORMAL DISTRIBUTION; PEPTIDES; TISSUE;

SCAFFOLDS (BIOLOGY);

ACTIN; AUTOLOGOUS FIBRIN SCAFFOLD; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; TISSUE SCAFFOLD; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL COUNT; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; COLLAGEN SYNTHESIS; COMPARATIVE STUDY; DERMAL FIBROBLAST; FIBROBLAST; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROCAPSULE; NONHUMAN; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DERMIS; DRUG COMPOUNDING; FIBRIN; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HUMANS; MATERIALS TESTING; SWINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, AUTOLOGOUS;

EID: 80255141925     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.33231     Document Type: Article

References (26)

1. Liu C, Xia Z, Czernuszka JT,. Design and development of three-dimensional scaffolds for tissue engineering. Trans IChemE Part A Chem Eng Res Des 2007; 85: 1051-1064. (Pubitemid 47241501)
2. Li Z, Ramay HR, Hauch HD, Xiao D, Zhang M,. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005; 26: 3919-3928. (Pubitemid 40038783)
3. Ahmed TA, Dare EV, Hincke M,. Fibrin: A versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 2008; 14: 199-215. (Pubitemid 351839214)
4. Jackson MR,. Fibrin sealants in surgical practice: An overview. Am J Surg 2001; 182: 1S-7S. (Pubitemid 32898601)
5. Silver FH, Wang MC, Pins GD,. Preparation and use of fibrin glue in surgery. Biomaterials 1995; 16: 891-903.
6. Linnes MP, Ratner BD, Giachelli CM,. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials 2007; 28: 5298-5306. (Pubitemid 47534237)
7. Herrero EP, Del Valle EM, Galán MA,. Development of a new technology for the production of microcapsules based in atomization processes. Chem Eng J 2006; 117: 137-142. (Pubitemid 43276464)
8. Del Valle EM, Galán MA, Herrero EP,. System for producing microcapsules and use thereof. Eur Pat EP101533198, 2010.
9. Nieto A, Areva S, Wilson T, Viitala R, Vallet-Regi M,. Cell viability in a wet silica gel. Acta Biomater 2009; 5: 3478-3487.
10. Nakayama GR, Caton MC, Nova MP, Parandoosh Z,. Assessment of the Alamar blue assay for cellular growth and viability in vitro. J Immunol Methods 1997; 204: 205-208. (Pubitemid 27262014)
11. Reiss RF, Oz MC,. Autologous fibrin glue: Production and clinical use. Transfus Med Rev 1996; 10: 85-92. (Pubitemid 26123864)
12. Alston SM, Solen KA, Sukavaneshvar S, Mohammad SF,. New method to prepare autologous fibrin glue on demand. Transl Res 2007; 149: 187-195. (Pubitemid 46442007)
13. Buchta C, Hedrich HC, Macher M, Höcker P, Redl H,. Biochemical characterization of autologous fibrin sealants produced by CryoSeal® and Vivostat® in comparison to the homologous fibrin sealant product Tissucol/Tisseel. Biomaterials 2005; 26: 6233-6241. (Pubitemid 40826992)
14. Clark RA,. Fibrin is a many splendored thing. J Invest Dermatol 2003; 121: xxi-xxii. (Pubitemid 37430957)
15. Ho W, Tawil B, Dunn JC, Wu Bm,. The behaviour of human mesenchymal stem cells in 3D fibrin clots: Dependence on fibrinogen concentration and clot structure. Tissue Eng 2006; 12: 1587-1595. (Pubitemid 44174792)
16. Yang YI, Seol DL, Kim HI, Cho MH, Lee SJ,. Composite fibrin and collagen scaffold to enhance tissue regeneration and angiogenesis. Curr Appl Phys 2007; 7S1: e103-e107. (Pubitemid 46283555)
17. Cox S, Cole M, Tawil B,. Behaviour of human dermal fibroblasts in three-dimensional fibrin clots: Dependence on fibrinogen and thrombin concentration. Tissue Eng 2004; 10: 942-954. (Pubitemid 38880413)
18. Vavken P, Joshi SM, Murray MM,. Fibrin concentration affects ACL fibroblast proliferation and collagen synthesis. The Knee 2011; 18: 42-46.
19. Zhao H, Ma L, Zhou J, Mao Z, Gao C, Shen J,. Fabrication and physical and biological properties of fibrin gel derived from human plasma. Biomed Mater 2008; 3: 015001.
20. Kobayashi K, Suzuki T, Nomoto Y, Tada Y, Miyake M, Hazama A, Nakamura T, Omori K,. Potential of heterotopic fibroblasts as autologous transplanted cells for tracheal epithelial regeneration. Tissue Eng 2007; 13: 2175-2184. (Pubitemid 47404433)
21. Jeon O, Ryu SH, Chung JH, Kim BS,. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J Control Release 2005; 105: 249-259. (Pubitemid 40941990)
22. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH,. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 2007; 2: 1123-1131. (Pubitemid 44809425)
23. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S,. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res 2003; 65A: 489-497. (Pubitemid 38075880)
24. Chen RR, Mooney DJ,. Polymeric growth factor delivery strategies for tissue engineering. Pharm Res 2003; 20: 1103-1112. (Pubitemid 36951832)
25. Akasaka Y, Ono I, Tominaga A, Ishikawa Y, Ito K, Suzuki T, Imaizumi R, Ishiguro S, Jimbow K, Ishii T,. Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of α-smooth muscle actin, leading to reduction of wound contraction. Wound Repair Regen 2007; 15: 378-389. (Pubitemid 46817414)
26. Ishiguro S, Akasaka Y, Kiguchi H, Suzuki T, Imaizumi R, Ishikawa Y, Ito K, Ishii T,. Basic fibroblast growth factor induces down-regulation of α-smooth muscle actin and reduction of myofibroblasts areas in open skin wounds. Wound Repair Regen 2009; 17: 617-625.